Resumption of Spermatogenesis and Fertility Post Withdrawal of Hydroxyurea Treatment

Resumption of Spermatogenesis and Fertility Post Withdrawal of Hydroxyurea Treatment

Hydroxyurea (HU), a drug for treating cancers of the blood and the management of sickle cell anemia, induces hypogonadism in males. However, the impact of HU on testicular architecture and function, as well as its effects on the resumption of male fertility following treatment withdrawal, remain poo...

Full description

Bibliographic Details
Main Authors: Carlos Virgous, Letitia Lyons, Amos Sakwe, Tultul Nayyar, Shawn Goodwin, James Hildreth, Kevin Osteen, Kaylon Bruner-Tran, Oluwatobi Alawode, Phillip Bourne, Edward Richard Hills, Anthony E. Archibong
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
hydroxyurea
male contraception
testis weight
sperm density
sperm motility
testosterone
Online Access:https://www.mdpi.com/1422-0067/24/11/9374

Internet

https://www.mdpi.com/1422-0067/24/11/9374

Similar Items